Louisiana Bydureon Lawsuit Attorneys
In 2005, the Food and Drug Administration (FDA) approved the use of the drug Byetta to help control blood sugar levels in patients with type-II diabetes. By 2010, the drug had proved so successful that it had been prescribed more than a million times. Louisiana Bydureon lawsuit attorneys know that this was a successful venture for marketer Amylin Pharmaceuticals, which at the time was sharing the marketing with Eli Lilly. A longer acting form of Byetta, called Bydureon, soon followed and was hailed as a newer and easier way to treat diabetes. It requires once-a-week injections rather than the twice daily shots needed for Byetta. In addition, also unlike Byetta, Bydureon can be injected at any time of the day and in different areas of the body, such as the chest, thigh, or upper arm.
What it Was Meant to Do and What it Does
Bydureon, Byetta, and other similar medications help to increase the production of insulin, which is produced in the pancreas to regulate blood glucose levels. When the pancreas does not produce insulin at the proper levels, type-II diabetes, a chronic disease, may be the result. The first sign of trouble concerning Byetta occurred in 2007. Warnings began to surface about a possible link between the drug and pancreatitus, an inflammation of the pancreas. The warnings cited some 30 users who had developed an acute type of the disease. Bydureon has now also been linked to pancreatic cancer, a condition that is both serious and life-threatening. Because its development does not generally cause early symptoms, it may well be in the late stages when it is discovered. Some symptoms attributed to pancreatic cancer are jaundice, which is a yellowing of the eyes or skin, general overall weakness, dark urine, nausea and vomiting, and upper abdomenal pain that spreads to the back or sides.
Bydureon has also been cited as a possible cause of thyroid cancer, which occurs just below the Adam’s apple in the butterfly-shaped gland at the base of the neck. The hormones produced in the thyroid regulate blood pressure and heart rate. The FDA report noted that thyroid tumors were produced in the test rats and monkeys given these diabetes-regulating drugs. Reportedly, the rate of thyroid cancer in the United States is on the increase, which is perhaps due to advanced technology that is able to discover smaller cancers in the area. With treatment, most cases of thyroid cancer can be cured. Warning signs of thyroid abnormalities include changes in the voice, pain in the throat or neck, swollen lymph nodes, and difficulty swallowing. Anyone who has taken Bydureon and is concerned about these reports should consult a doctor as well as Louisiana Bydureon lawsuit attorneys. The charges against this drug are serious and can be investigated.
How Can the Louisiana Bydureon Lawsuit Attorneys Help Your Case?
- Louisiana Bydureon lawsuit attorneys will begin the investigation with a free
and confidential consultation.
- Louisiana Bydureon lawsuit attorneys are experienced in personal injury cases.
- Louisiana Bydureon lawsuit attorneys know the areas to explore, such as
whether the manufacturer gave adequate warnings about possible side effects
with the drug.
- Louisiana Bydureon lawsuit attorneys have one goal: to protect your rights.
You Are Not Alone
If you or a loved one is concerned with the possibility of serious side effects through the use of Bydureon, don’t hesitate to get help, both medical and legal. Louisiana Bydureon lawsuit attorneys have the experience to guide you through this type of fight for your rights. Are you due compensation for what has happened as a result of taking the drug? Louisiana Bydureon lawsuit attorneys can pursue your claims for compensation if you are found eligible. Don’t fight this battle alone. Contact Louisiana Bydureon lawsuit attorneys today.